updates

Portfolio and APVC news

20 October 2020

Watch the APVC team speak at the 2020 Medtech Strategists Virtual Summit about bioelectronic medicine, investments, trends, and their commitment to diversity & inclusion.

News & Comments
read more
31 August 2020

Listen to APVC partner Juan-Pablo Mas speak with Tom Salemi of the Device Talks Weekly podcost about the potential of ultrasound in bioelectronic medicine

News & Comments
read more
27 January 2021

SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform

Portfolio News
read more
News & Comments
26 January 2021

We are proud to announce that APVC Executive-in-Residence, Rami Elghandour was recently appointed Chairman of the Board and CEO of Arcellx. Rami will lead Arcellx as it advances its transformative cancer and autoimmune therapies.

read more
Portfolio News
3 December 2020

CVRx Barostim Therapy Receives CMS Approval for Transitional Pass-Through Payment Status

read more
Portfolio News
22 October 2020

Cala Health Receives FDA Breakthrough Designation for Cala Trio Therapy to Treat Action Tremors in Parkinson's Disease

read more
Portfolio News
9 October 2020

Axon Therapies Announces Positive Results From First In-Human Clinical Study in Late Breaking Clinical Trial Session at 2020 Virtual HFSA Conference

read more
Portfolio News
6 October 2020

SetPoint Medical Receives FDA Breakthrough Designation for Its Novel Bioelectronic Platform

read more
Portfolio News
1 October 2020

CVRx's Barostim Neo Receives CMS NTAP

read more
your details
upload a document
Upload icon
upload
your message

This website and the contact information contained therein is not intended for reporting adverse events. If you have a question about a GSK product or want to report a side effect, please call the GSK Response Center at 1-888-825-5249. Monday-Friday, 8:00 am - 6:00 pm ET

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.